Zobrazeno 1 - 10
of 413
pro vyhledávání: '"Abs R"'
Autor:
Abs, R.
Publikováno v:
In Annales de chirurgie plastique esthétique November 2019 64(5-6):653-659
Publikováno v:
In EMC Tecniche chirurgiche Chirurgia Plastica, Ricostruttiva ed Estetica September 2015 13(3):1-10
Publikováno v:
In Annales de chirurgie plastique esthétique April 2015 60(2):110-116
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
HUIZENGA NA, KOPER JW, DE HERDER WW, ABS R, VAN KATEREN JH, DE JONG FH, LAMBERTS SW, DE LANGE, Pieter
Publikováno v:
The journal of clinical endocrinology and metabolism
Journal of Clinical Endocrinology and Metabolism, 85(5), 2076-2081. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 85(5), 2076-2081. Endocrine Society
Cortisol resistance (CR) is a rare disease characterized by a generalized reduced sensitivity of end-organs to the actions of glucocorticoids (GCs). GC effects are mediated by the GC receptor (GR). The molecular alterations in CR described thus far w
Publikováno v:
Tijdschrift voor Geneeskunde. 62:213-218
Publikováno v:
Tijdschrift voor Geneeskunde. 62:208-212
Publikováno v:
Tijdschrift voor Geneeskunde. 62:219-222
Autor:
Touraine, P, D'Souza, Ga, Kourides, I, Abs, R, Barclay, P, Xie, R, Pico, A, Torres Vela, E, Ekman, B, GH Lipoatrophy Study Group, Andersen, M, Beck Peccoz, P, Beckers, A, Bex, Ma, Bornstein, Sr, Cannavo', Salvatore, Cap, J, Chanson, P, Colao, Am, Faust, M, Halperin, I, Karbownik Lewinska, M, De Marinis, L, Drake, Wm, Erfurth, Em, Ghigo, E, Hana, V, Kann, Ph, Laurberg, P, Miell, Jp, Milewicz, A, Payer, J, Pereira, Am, T'Sjoen, G, Sowinski, J, Stalla, Gk, Trainer, Pj, Wass, J, Brue, T, Casanueva, Ff, Czernichow, P, Delemer, B, De Schepper, J, Feldt Rasmussen, U, Gregory, Jw, Jørgensen, Jo, Johannsson, G, Kristensen, Lo, Mattsson, C, Pura, M, Vanuga, P.
Publikováno v:
European journal of endocrinology
Andersen, M & GH Lipoatrophy Study Group 2009, ' Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH ', European Journal of Endocrinology, vol. 161, no. 4, pp. 533-540 . https://doi.org/10.1530/EJE-09-0422
Touraine, P, D'Souza, G A, Kourides, I, Abs, R, Barclay, P, Xie, R, Pico, A, Torres-Vela, E, Ekman, B, GH Lipoatrophy Study Group & Jørgensen, J O L 2009, ' Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH ', European Journal of Endocrinology, vol. 161, no. 4, pp. 533-40 . https://doi.org/10.1530/EJE-09-0422
Andersen, M & GH Lipoatrophy Study Group 2009, ' Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH ', European Journal of Endocrinology, vol. 161, no. 4, pp. 533-540 . https://doi.org/10.1530/EJE-09-0422
Touraine, P, D'Souza, G A, Kourides, I, Abs, R, Barclay, P, Xie, R, Pico, A, Torres-Vela, E, Ekman, B, GH Lipoatrophy Study Group & Jørgensen, J O L 2009, ' Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH ', European Journal of Endocrinology, vol. 161, no. 4, pp. 533-40 . https://doi.org/10.1530/EJE-09-0422
ObjectiveChanges observed during adult GH deficiency (GHD) are most often reversed with the administration of recombinant human GH (rhGH). To avoid daily injections, a long-acting GH molecule has been obtained by covalent binding of polyethylene glyc
Publikováno v:
Tijdschrift voor Geneeskunde. 54:268-271